Literature DB >> 9635801

Diagnosis and treatment of sphincter of Oddi dysfunction.

G Tzovaras1, B J Rowlands.   

Abstract

UNLABELLED: BACKGROUND Sphincter of Oddi dysfunction is a challenge from both the diagnostic and therapeutic point of view. There is much ongoing debate about the accuracy and usefulness of various diagnostic tests, as there is about the effectiveness of proposed therapeutic alternatives.
METHODS: A comprehensive review of the past 15 years' literature was undertaken, using the Medline database and cross-referencing of major articles on the subject. RESULTS AND
CONCLUSION: Endoscopic and surgical treatments result in similar outcomes, with considerable failure rates. The latter reflect the difficulties in accurate diagnosis and a lack of sound objective criteria for selecting patients for intervention. In addition, in some patients sphincter of Oddi dysfunction may be only part of a generalized motility disorder of the gastrointestinal tract.

Entities:  

Mesh:

Year:  1998        PMID: 9635801     DOI: 10.1046/j.1365-2168.1998.00766.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  12 in total

Review 1.  Efficacy of biliary scintigraphy in suspected sphincter of Oddi dysfunction.

Authors:  S Jagannath; A N Kalloo
Journal:  Curr Gastroenterol Rep       Date:  2001-04

2.  Pancreaticobiliary reflux in patients with and without cholelithiasis: is it a normal phenomenon?

Authors:  Marcelo A Beltrán; Mario A Contreras; Karina S Cruces
Journal:  World J Surg       Date:  2010-12       Impact factor: 3.352

3.  Sphincter of Oddi disorder: what is the clinical issue?

Authors:  Hiromu Kutsumi; Kentaro Nobutani; Saori Kakuyama; Hideyuki Shiomi; Eiji Funatsu; Atsuhiro Masuda; Maki Sugimoto; Masaru Yoshida; Tsuyoshi Fujita; Takanobu Hayakumo; Takeshi Azuma
Journal:  Clin J Gastroenterol       Date:  2011-10-27

4.  The effects of morphine-neostigmine and secretin provocation on pancreaticobiliary morphology in healthy subjects: a randomized, double-blind crossover study using serial MRCP.

Authors:  Abeed H Chowdhury; David J Humes; Susan E Pritchard; Luca Marciani; Penny A Gowland; John Simpson; Dileep N Lobo
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

5.  Late development of bile duct cancer in patients who had biliary-enteric drainage for benign disease: a follow-up study of more than 1,000 patients.

Authors:  A Tocchi; G Mazzoni; G Liotta; L Lepre; D Cassini; M Miccini
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

6.  Medical treatment for sphincter of oddi dysfunction: can it replace endoscopic sphincterotomy?

Authors:  Véronique Vitton; Salah Ezzedine; Jean-Michel Gonzalez; Mohamed Gasmi; Jean-Charles Grimaud; Marc Barthet
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

7.  Endoscopic sphincterotomy for stenosis of the sphincter of Oddi.

Authors:  C Sugawa; D H Park; C E Lucas; D Higuchi; K Ukawa
Journal:  Surg Endosc       Date:  2001-07-05       Impact factor: 4.584

8.  Relative effects of dihydropyridine L-type calcium channel antagonism on biliary, duodenal, and vascular tissues: an in vivo and in vitro analysis in Australian brush-tailed possum.

Authors:  A G Craig; A Tottrup; J Toouli; G T P Saccone
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

9.  Sphincter of Oddi manometry using guide-wire-type manometer is feasible for examination of sphincter of Oddi motility.

Authors:  Saori Kakuyama; Kentaro Nobutani; Atsuhiro Masuda; Hideyuki Shiomi; Tsuyoshi Sanuki; Maki Sugimoto; Masaru Yoshida; Yoshifumi Arisaka; Tsuyoshi Fujita; Takanobu Hayakumo; Takeshi Azuma; Hiromu Kutsumi
Journal:  J Gastroenterol       Date:  2012-11-20       Impact factor: 7.527

10.  Biliary sphincter of Oddi dysfunction type I versus occult biliary microlithiasis in post-cholecystectomy patients: are they both part of the same clinical entity?

Authors:  Farshad Elmi; William B Silverman
Journal:  Dig Dis Sci       Date:  2009-04-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.